MRI Guided Management of Occlusive Peripheral Arterial Disease
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The Methodist Hospital Research Institute
- Study ID
- NCT06782100
- Status
- Recruiting
Conditions
- Peripheral Vascular Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize vessel wall injury. Patients undergoing intervention will have an MRI scan prior to their planned percutaneous vascular intervention to assess the plaque and predict procedural difficulty. Patients undergoing lower limb amputation due to peripheral arterial disease will have their limbs included into a second arm of the study The limb will undergo an MRI scan to assess the plaque. The investigator will then test two different devices and assess the effects of these devices on the vessel wall.
Key Dates
- Start date
- Jul 1, 2024
- Status verified
- Mar 2026
- Primary completion
- Jul 1, 2028
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 175 participants (estimated)
Arms
- Arm: Amputation ArmIn an ex vivo human cadaveric model, post-PVI histopathologic analysis will be used to uncover the impact of plaque type on device safety (POBA versus atherectomy) and performance, facilitating evidence-based device selection to mitigate complications. Using a randomized approach, the investigator will compare plain balloon angioplasty to orbital atherectomy prior to angioplasty in amputated legs from PAD patients with plaques characterized into 4 categories based their MRI-histology: concentric calcium, eccentric calcium, fibrous plaque, and soft plaques (smooth muscle and thrombus).
- Arm: Revascularization ArmPatient Imaging Protocol: Scans will be performed on 100 patients enrolled into the study population using a 3T MAGNETOM scanner (Siemens) at the Houston Methodist Research Institute Translational Imaging Center. The investigator will use pre-operative images captured using the optimized MRI-histology sequences to score lesions. Physicians performing PVI will be blinded to the pre-operative MRI-histology images and anatomic scores and will make treatment decisions based on their standard of care. The investigator expect MRI-histology plaque scores predict which patients will have PVI failures due to untraversable plaque, and it may also foresee the potential need of adjunctive devices or alternative approaches for successful PVI
Primary Outcome Measure
Patient primary Outcome [ Time Frame: Intraprocedural - the outcome is at the time of the procedure, it is not a follow up outcome. ]
Central Contacts
- Trisha Roy, MD, PhD713-441-5200
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Houston Methodist Hospital | Houston | Texas | 77030 | Trisha Roy, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral VasculatureRecruiting · Boston Scientific Corporation · Jonesboro, Arkansas
- Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1Recruiting · Virginia Commonwealth University · Richmond, Virginia
- Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3Recruiting · Virginia Commonwealth University · Richmond, Virginia
- Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2Recruiting · Virginia Commonwealth University · Richmond, Virginia